Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2006-05-09
2006-05-09
Davis, Zinna Northington (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C546S148000, C546S149000, C546S168000, C546S169000, C544S363000, C514S233500, C514S253060, C514S299000, C514S307000, C514S313000, C514S314000, C206S828000
Reexamination Certificate
active
07041664
ABSTRACT:
Disclosed are compounds of the formula:or pharmaceutically acceptable salts or pharmaceutically acceptable solvates thereof,wherein R1, R2, R3, X, Q1and Q2are defined herein,which compounds are ligands for neurokinin receptors, in particular NK-3 receptors, and are therefor useful in the treatment of a wide range of diseases or disorders including, but not limited to depression, anxiety, psychosis, obesity, pain, Parkinson's disease, Alzheimer's disease, neurodegenerative diseases, movement disorders, respiratory diseases, inflammatory diseases, neuropathy, immune disorders, migraine, biliary disfunction, and dermatitis.
REFERENCES:
patent: 5340822 (1994-08-01), Emonds-Alt et al.
patent: 5434158 (1995-07-01), Shah
patent: 6369053 (2002-04-01), Yuan et al.
patent: 0 512 901 (1994-04-01), None
patent: 53-44577 (1992-04-01), None
patent: WO 95/32948 (1995-12-01), None
patent: WO 96/02509 (1996-02-01), None
patent: WO 97/19926 (1997-06-01), None
patent: WO 97/19928 (1997-06-01), None
patent: WO 97/21680 (1997-06-01), None
patent: WO 98/41506 (1998-09-01), None
patent: WO 98/52942 (1998-11-01), None
Batt et al., Bioorg. Med. Chem. Lett., 1998, 8, pp. 1745-1750.
Boden, Phil et al., “Use of a Dipeptide Chemical Library in the Development of Non-Peptide Tachykinin NK3Receptor Selective Antagonists”,J. Med. Chem. 1996, 39, 1664-1675.
Buchwald et al. J. Org. Chem., 2000, 65, pp. 11444-11474.
Giardina et al., (1997) “Discovery of a Novel Class of Selective Non-Peptide Antagonists for the Human Neurokinin-3-Receptor. 1. Identification of the 4-Quinolinecarboxamide Framework”,Journal of Medicinal Chemistry, vol. 40, pp. 1794-1807.
Jacobs et al., Org. Synth. Coll., 1955, 3, pp. 456-458.
Lyle et al., J. Org. Chem. , 1972, 37, pp. 3967-3968.
Hutchison Alan
Maynard George
Yuan Jun
Davis Zinna Northington
McDonnell Boehnen & Hulbert & Berghoff LLP
Neurogen Corporation
LandOfFree
2-aminoquinolinecarboxamides: neurokinin receptor ligands does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 2-aminoquinolinecarboxamides: neurokinin receptor ligands, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2-aminoquinolinecarboxamides: neurokinin receptor ligands will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3597486